Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 116342856 | 11634285 | 6 | F | 20140206 | 20160813 | 20151015 | 20160817 | EXP | US-AMGEN-2014-0318 | AMGEN | 70.00 | YR | E | M | Y | 79.36000 | KG | 20160816 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 116342856 | 11634285 | 1 | PS | carfilzomib | CARFILZOMIB | 1 | Intravenous (not otherwise specified) | 70 MG/M2, PER CHEMO REGIM | Y | A79155 | 202714 | 70 | MG/M**2 | INTRAVENOUS INFUSION | |||||
| 116342856 | 11634285 | 2 | SS | DEXAMETHASONE. | DEXAMETHASONE | 1 | Intravenous (not otherwise specified) | 40 MG, PER CHEMO REGIM | Y | 0 | 40 | MG | UNKNOWN FORMULATION | ||||||
| 116342856 | 11634285 | 3 | C | SALINE | SODIUM CHLORIDE | 1 | Intravenous (not otherwise specified) | 3 TO 1000 ML, QD | 0 | QD | |||||||||
| 116342856 | 11634285 | 4 | C | ACETAMINOPHEN. | ACETAMINOPHEN | 1 | Oral | 1000 MG, UNK | 0 | 1000 | MG | ||||||||
| 116342856 | 11634285 | 5 | C | PHENERGAN VC W/ CODEINE | CODEINE PHOSPHATEPHENYLEPHRINE HYDROCHLORIDEPROMETHAZINE HYDROCHLORIDE | 1 | Oral | UNK | 0 | ||||||||||
| 116342856 | 11634285 | 6 | C | METOPROLOL. | METOPROLOL | 1 | Oral | 50 MG, QD | 0 | 50 | MG | QD | |||||||
| 116342856 | 11634285 | 7 | C | HYDROCHLOROTHIAZIDE. | HYDROCHLOROTHIAZIDE | 1 | Oral | 25 MG, QD | 0 | 25 | MG | QD | |||||||
| 116342856 | 11634285 | 8 | C | OXYCOCET | ACETAMINOPHENOXYCODONE HYDROCHLORIDE | 1 | Oral | UNK | 0 | ||||||||||
| 116342856 | 11634285 | 9 | C | TIMOLOL. | TIMOLOL | 1 | INTRA-AURAL | 2 GTT, QD | 0 | 2 | GTT | QD | |||||||
| 116342856 | 11634285 | 10 | C | ZYRTEC | CETIRIZINE HYDROCHLORIDE | 1 | Oral | 10 MG, QD | 0 | 10 | MG | QD | |||||||
| 116342856 | 11634285 | 11 | C | ACYCLOVIR. | ACYCLOVIR | 1 | Oral | 400 MG, BID | 0 | 400 | MG | BID | |||||||
| 116342856 | 11634285 | 12 | C | ALPHA LIPOIC ACID | .ALPHA.-LIPOIC ACID | 1 | Oral | 600 MG, QD | 0 | 600 | MG | QD | |||||||
| 116342856 | 11634285 | 13 | C | ALPHA LIPOIC ACID | .ALPHA.-LIPOIC ACID | 1 | 0 | ||||||||||||
| 116342856 | 11634285 | 14 | C | ZOMETA | ZOLEDRONIC ACID | 1 | Intravenous (not otherwise specified) | 4 MG, QMO | 0 | 4 | MG | /month | |||||||
| 116342856 | 11634285 | 15 | C | ZOMETA | ZOLEDRONIC ACID | 1 | 0 | ||||||||||||
| 116342856 | 11634285 | 16 | C | PERCOCET | ACETAMINOPHENOXYCODONE HYDROCHLORIDE | 1 | Oral | 5 MG, PRN | 0 | 5 | MG | ||||||||
| 116342856 | 11634285 | 17 | C | AMBIEN | ZOLPIDEM TARTRATE | 1 | Oral | 10 MG, QD | 0 | 10 | MG | QD | |||||||
| 116342856 | 11634285 | 18 | C | AVELOX | MOXIFLOXACIN HYDROCHLORIDE | 1 | Oral | 400 MG, UNK | 0 | 400 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 116342856 | 11634285 | 1 | Plasma cell myeloma |
| 116342856 | 11634285 | 2 | Plasma cell myeloma |
| 116342856 | 11634285 | 3 | Catheter management |
| 116342856 | 11634285 | 4 | Product used for unknown indication |
| 116342856 | 11634285 | 5 | Cough |
| 116342856 | 11634285 | 6 | Hypertension |
| 116342856 | 11634285 | 7 | Hypertension |
| 116342856 | 11634285 | 8 | Product used for unknown indication |
| 116342856 | 11634285 | 9 | Intraocular pressure test |
| 116342856 | 11634285 | 10 | Hypersensitivity |
| 116342856 | 11634285 | 11 | Antiviral prophylaxis |
| 116342856 | 11634285 | 12 | Neuropathy peripheral |
| 116342856 | 11634285 | 13 | Prophylaxis |
| 116342856 | 11634285 | 14 | Bone loss |
| 116342856 | 11634285 | 15 | Prophylaxis |
| 116342856 | 11634285 | 16 | Pain |
| 116342856 | 11634285 | 17 | Insomnia |
| 116342856 | 11634285 | 18 | Upper respiratory tract infection |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 116342856 | 11634285 | LT |
| 116342856 | 11634285 | HO |
| 116342856 | 11634285 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 116342856 | 11634285 | Acute kidney injury | |
| 116342856 | 11634285 | Atrial fibrillation | |
| 116342856 | 11634285 | Cardio-respiratory arrest | |
| 116342856 | 11634285 | Metabolic acidosis | |
| 116342856 | 11634285 | Pneumonia influenzal | |
| 116342856 | 11634285 | Respiratory failure | |
| 116342856 | 11634285 | Septic shock | |
| 116342856 | 11634285 | Thrombocytopenia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 116342856 | 11634285 | 1 | 20131104 | 20140204 | 0 | |
| 116342856 | 11634285 | 2 | 20131104 | 20140204 | 0 | |
| 116342856 | 11634285 | 3 | 20140204 | 20140210 | 0 | |
| 116342856 | 11634285 | 4 | 20140204 | 20140204 | 0 | |
| 116342856 | 11634285 | 11 | 20130502 | 0 | ||
| 116342856 | 11634285 | 12 | 20130502 | 0 | ||
| 116342856 | 11634285 | 14 | 20130503 | 0 | ||
| 116342856 | 11634285 | 16 | 20130531 | 0 | ||
| 116342856 | 11634285 | 17 | 20130705 | 0 | ||
| 116342856 | 11634285 | 18 | 20140202 | 0 |